FindTrial
Sign In

Research and Clinical Practice of a new model of cancer clinical pathway for comprehensive management of non-metastatic nasopharyngeal carcinoma, breast cancer and colon cancer

Research and application of management system for cancer clinical pathway

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17012815
Enrollment
Unknown
Registered
2017-09-26
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma, breast cancer and colon cancer

Interventions

Case series:Nil

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Newly pathologically diagnosed nasopharyngeal carcinoma, stage I, II, III, IVA, IVB; Newly pathologically diagnosed breast ductal invasive carcinoma; Newly pathologically diagnosed colon cancer, stage I, II, III. Aged 18-70 years old male or female.

Exclusion criteria

Exclusion criteria: Comobdities with psychiatric disorders that can not be complined with treatment. With onther primary malignancy within 6 monthes scince diagnosis.

Design outcomes

Primary

MeasureTime frame
enrollment ratio;completion rate;rate of deviation;—

Countries

China

Contacts

Public ContactLee A W

The University of Hong Kong-Shenzhen Hospital

awmlee@hku.hk+86 18033050750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026